REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q4 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $602,806 | +17.3% | 3,791 | +24.2% | 0.00% | 0.0% |
Q2 2023 | $513,834 | 0.0% | 3,052 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $513,834 | -0.3% | 3,052 | +0.2% | 0.00% | 0.0% |
Q4 2022 | $515,548 | -7.3% | 3,045 | +2.2% | 0.00% | -25.0% |
Q3 2022 | $556,000 | -53.4% | 2,979 | -59.5% | 0.00% | -42.9% |
Q2 2022 | $1,194,000 | +67.5% | 7,361 | +93.9% | 0.01% | +75.0% |
Q1 2022 | $713,000 | -5.9% | 3,796 | +32.3% | 0.00% | 0.0% |
Q4 2021 | $758,000 | -28.0% | 2,869 | -21.3% | 0.00% | -20.0% |
Q3 2021 | $1,053,000 | +20.9% | 3,646 | -16.5% | 0.01% | 0.0% |
Q2 2021 | $871,000 | +1.2% | 4,369 | -1.5% | 0.01% | 0.0% |
Q1 2021 | $861,000 | +4.0% | 4,434 | +2.5% | 0.01% | 0.0% |
Q4 2020 | $828,000 | +18.6% | 4,324 | -8.7% | 0.01% | +25.0% |
Q3 2020 | $698,000 | +30.0% | 4,734 | +8.9% | 0.00% | +33.3% |
Q2 2020 | $537,000 | -3.6% | 4,347 | -27.8% | 0.00% | 0.0% |
Q1 2020 | $557,000 | 0.0% | 6,022 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $557,000 | +48.5% | 6,022 | +23.1% | 0.00% | +50.0% |
Q3 2019 | $375,000 | +131.5% | 4,893 | +159.6% | 0.00% | +100.0% |
Q2 2019 | $162,000 | +57.3% | 1,885 | +8.1% | 0.00% | – |
Q1 2019 | $103,000 | +14.4% | 1,744 | +1.5% | 0.00% | – |
Q4 2018 | $90,000 | -18.2% | 1,719 | -13.7% | 0.00% | – |
Q3 2018 | $110,000 | +17.0% | 1,991 | -0.3% | 0.00% | – |
Q2 2018 | $94,000 | +46.9% | 1,996 | +10.8% | 0.00% | – |
Q1 2018 | $64,000 | 0.0% | 1,801 | 0.0% | 0.00% | – |
Q4 2017 | $64,000 | +8.5% | 1,801 | +15.2% | 0.00% | – |
Q3 2017 | $59,000 | +3.5% | 1,564 | -4.1% | 0.00% | – |
Q2 2017 | $57,000 | 0.0% | 1,631 | 0.0% | 0.00% | – |
Q1 2017 | $57,000 | +21.3% | 1,631 | +7.0% | 0.00% | – |
Q4 2016 | $47,000 | +2.2% | 1,525 | 0.0% | 0.00% | – |
Q3 2016 | $46,000 | +12.2% | 1,525 | 0.0% | 0.00% | – |
Q2 2016 | $41,000 | -6.8% | 1,525 | -9.4% | 0.00% | – |
Q1 2016 | $44,000 | +2.3% | 1,684 | +10.6% | 0.00% | – |
Q4 2015 | $43,000 | +43.3% | 1,523 | +38.7% | 0.00% | – |
Q3 2015 | $30,000 | -26.8% | 1,098 | +7.4% | 0.00% | – |
Q2 2015 | $41,000 | +2.5% | 1,022 | -24.3% | 0.00% | – |
Q1 2015 | $40,000 | +53.8% | 1,350 | 0.0% | 0.00% | – |
Q4 2014 | $26,000 | 0.0% | 1,350 | 0.0% | 0.00% | – |
Q3 2014 | $26,000 | -16.1% | 1,350 | -3.6% | 0.00% | – |
Q2 2014 | $31,000 | – | 1,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |